Business Description
Endonovo Therapeutics Inc
NAICS : 325412
SIC : 2834
ISIN : US29272H3003
Description
Endonovo Therapeutics Inc develops, manufactures and distributes revolutionary medical devices that utilize Pulsed Electro Magnetic Field (PEMF) therapy that are focused on the rapid recovery of wounds and reduction of pain, edema and inflammation on and in the human body.
Financial Strength
| Name | Current | Vs Industry | Vs History |
|---|
Growth Rank
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
9-Day RSI | 66.05 | |||||
14-Day RSI | 59.36 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History |
|---|
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History |
|---|
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
FCF Margin % | 770 | |||||
OCF Margin % | 770 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
EV-to-EBIT | -5.8 | |||||
EV-to-EBITDA | -7.64 | |||||
EV-to-Revenue | 707.7 | |||||
EV-to-FCF | 91.91 | |||||
Earnings Yield (Greenblatt) % | -17.24 | |||||
FCF Yield % | 42.54 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:ENDV
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Endonovo Therapeutics Inc Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 0.01 | ||
| EPS (TTM) ($) | -0.003 | ||
| Beta | 51.8135 | ||
| 3-Year Sharpe Ratio | -0.69 | ||
| 3-Year Sortino Ratio | -0.99 | ||
| Volatility % | 171.54 | ||
| 14-Day RSI | 59.36 | ||
| 14-Day ATR ($) | 0.000007 | ||
| 20-Day SMA ($) | 0.0001 | ||
| 12-1 Month Momentum % | - | ||
| 52-Week Range ($) | 0.00005 - 0.0003 | ||
| Shares Outstanding (Mil) | 1,807.56 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 0 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Endonovo Therapeutics Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Endonovo Therapeutics Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| 0.001:1 Stock Split | 2019-12-20 | 1.30 (+4.00%) | ||
| 0.01:1 Stock Split | 2014-05-15 | 10,000.00 (+0.00%) |
Show
Entries
Endonovo Therapeutics Inc Frequently Asked Questions
What is Endonovo Therapeutics Inc(ENDV)'s stock price today?
The current price of ENDV is $0.00. The 52 week high of ENDV is $0.00 and 52 week low is $0.00.
When is next earnings date of Endonovo Therapeutics Inc(ENDV)?
The next earnings date of Endonovo Therapeutics Inc(ENDV) is .
Does Endonovo Therapeutics Inc(ENDV) pay dividends? If so, how much?
Endonovo Therapeutics Inc(ENDV) does not pay dividend.
Guru Commentaries on OTCPK:ENDV
No articles.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Endonovo Therapeutics Inc
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers